Open access · CC-BY
via OpenAlex
A Klotho-Based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease
Yating Wang, Yu Shi, Tangli Xiao, Xianjin Bi, Qingyu Huo, Shaobo Wang, Jiachuan Xiong, Jinghong Zhao
Kidney Diseases · 2024 · ▲ 4 citations
Abstract
Introduction: This study aimed to develop and validate machine learning (ML) models based on serum Klotho for predicting end-stage kidney disease (ESKD) and cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). Methods: Five different ML models were trained to predict the risk of ESKD and CVD at three different time points (3, 5, and 8 years) using a cohort of 400 non-dialysis CKD patients. The dataset was divided into a training set (70%) and an internal validation set (30%). These models were informed by data comprising 47 clinical features, including serum Klotho. The best-performing model was selected and used to identify risk factors for each outcome. Model performance was assessed using various metrics. Results: The findings showed that the least absolute shrinkage and selection operator regression model had the highest accuracy (C-index = 0.71) in predicting ESKD. The features mainly included in this model were estimated glomerular filtration rate, 24-h urinary microalbumin, serum albumin, phosphate, parathyroid hormone, and serum Klotho, which achieved the highest area under the curve (AUC) of 0.930 (95% CI: 0.897-0.962). In addition, for the CVD risk prediction, the random survival forest model with the highest accuracy (C-index = 0.66) was selected and achieved the highest AUC of 0.782 (95% CI: 0.633-0.930). The features mainly included in this model were age, history of primary hypertension, calcium, tumor necrosis factor-alpha, and serum Klotho. Conclusion: We successfully developed and validated Klotho-based ML risk prediction models for CVD and ESKD in CKD patients with good performance, indicating their high clinical utility.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1159/000538510
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Wang, Y., Shi, Y., Xiao, T., Bi, X., Huo, Q., Wang, S., Xiong, J., & Zhao, J. (2024). A Klotho-Based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease. <em>Kidney Diseases</em>. https://doi.org/10.1159/000538510
Vancouver
Wang Y, Shi Y, Xiao T, Bi X, Huo Q, Wang S, et al. A Klotho-Based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease. Kidney Diseases. 2024. doi:10.1159/000538510.
BibTeX
@article{yating2024AKloth,
title = {A Klotho-Based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease},
author = {Yating Wang and Yu Shi and Tangli Xiao and Xianjin Bi and Qingyu Huo and Shaobo Wang and Jiachuan Xiong and Jinghong Zhao},
journal = {Kidney Diseases},
year = {2024},
doi = {10.1159/000538510},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Nephrology 2026
Citation only
Epigenetic age enhances eGFR-based prediction of all-cause mortality: A cross-cohort validation of a novel risk model
Medicine 2025
Open access · CC-BY
Aging acceleration, not chronological age, is associated with cognitive performance in older adults: A cross-sectional study on the protective role of physical activity
medRxiv 2021
Preprint · CC-BY
Machine Learning and Prediction of All-Cause Mortality among Chinese Older Adults
Medical Bulletin of Haseki 2026
Open access · CC-BY
Association of Circulating FGF-23 and Klotho with Cardiovascular Disease in Patients with Chronic Kidney Disease
Communications Medicine 2025
Open access · CC-BY
Plasma-based brain age as a potential biomarker for cognitive health and risk of brain-related disorders
2022
Open access · CC0